FindTrial
Sign In

The effects of CoQ10 on prevention of altitude hypoxia exposure on cardiopulmonary function in healthy people

The effects of CoQ10 on prevention of altitude hypoxia exposure on cardiopulmonary function in healthy people

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066328
Enrollment
Unknown
Registered
2022-12-01
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Altitude sickness and inadaptation

Interventions

experimental group:CoQ10 100mg twice a day
control group:placebo 100mg twice a day

Sponsors

Second Affiliated Hospital of Army Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Be born and live in low altitude for a long time; 2. Healthy males and females aged between 17 and 60.

Exclusion criteria

Exclusion criteria: 1. Cardiovascular diseases; 2. Lung disease and other respiratory diseases; 3. Blood diseases; 4. Exposure history of plateau area within half a year.

Design outcomes

Primary

MeasureTime frame
maximum oxygen uptake;oxygen pulse;oxyhemoglobin saturation;metabolic equivalent;anaerobic threshold;Oxygen uptake and power slope;heart rate;RER;BP;VE;VE/VO2;VE/VCO2;NE;PRA;NPY;FFA;INS;LDH;EPI;ANG ?;ACE ?;ANP;LA;blood fat(TC?TG?LDL?HDL);blood glucose;PG;—

Countries

China

Contacts

Public ContactLan Huang

Second Affiliated Hospital of Army Military Medical University

huanglan260@126.com13808398102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026